Dutch Medicines Evaluation Board (CBG)

The Dutch Medicines Evaluation Board (CBG) is a regulatory agency in the Netherlands responsible for assessing and approving medicines to ensure they are safe, effective, and of good quality before they are made available to patients. It reviews scientific data from pharmaceutical companies, monitors medicines after approval, and enforces regulations to protect public health. The CBG collaborates with European and international organizations to harmonize standards and oversee the safe use of medicines within the country.